SCHEMBL14885684

SCHEMBL14885684

Cc1cc2c(cc1-c1ccc(NC(=O)c3oc(-c4ccccc4)nc3C)nc1)OC(F)(F)O2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STIM1 Q13586 4/20 0.49
▸ ORAI1 Q96D31 4/20 0.49
▸ GAA P10253 1/20 0.48
▸ DGAT1 O75907 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.42
▸ ORAI2 Q96SN7 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ ABL1 P00519 2/20 0.40
▸ NR1I2 O75469 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ CYP2C8 P10632 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CFTR P13569 1/20 0.38
▸ ADRA1A P35348 1/20 0.38
▸ PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16018220 0.91 STIM1 (0.49) STIM1ORAI1GAADGAT1KDM4E
SCHEMBL16018207 0.89 STIM1 (0.51) STIM1ORAI1GAADGAT1KDM4E
SCHEMBL16017215 0.89 GAA (0.50) STIM1ORAI1GAADGAT1KDM4E
SCHEMBL16018189 0.88 STIM1 (0.52) STIM1ORAI1GAAORAI2USP2
SCHEMBL12155538 0.83 STIM1 (0.57) STIM1ORAI1KDM4EORAI2MAPT
SCHEMBL14885688 0.82 STIM1 (0.52) STIM1ORAI1ORAI2POLBMAPT
SCHEMBL16018247 0.82 STIM1 (0.61) STIM1ORAI1GAADGAT1KDM4E
SCHEMBL14885675 0.81 MEN1 (0.50) STIM1ORAI1GAADGAT1ORAI2
SCHEMBL16018236 0.80 STIM1 (0.50) STIM1ORAI1DGAT1ORAI2MAPT
SCHEMBL12155518 0.80 STIM1 (0.56) STIM1ORAI1GAAKDM4EORAI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9856240-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2018-01-02 — — US disclosed
US-20140256745-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2014-09-11 — — US disclosed
US-20140256745-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2014-09-11 — — US disclosed
WO-2013059677-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-04-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256745-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 STIM1 17/4885ORAI1 1/4885GAA 994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback